A new RANZCO-hosted webinar series, introduced in response to COVID-19, is in high demand, with more than 200 professionals tuning in weekly to hear leading Australian and New Zealand experts discuss the latest evidence-based practices in ophthalmology.
As the CPD program continues to gather momentum, Fellows and trainees are now calling for the college to make the trial a permanent fixture.
Following the COVID-19 outbreak – and as many ophthalmology services were reduced due to the lockdown – RANZCO initiated the weekly webinar series for trainees and extended the invitation to all Fellows between 17 April and 19 June.
The webinars occur every Friday from 1–2pm, with a leading expert invited each week to showcase the latest evidence-based practice in ophthalmology. In the first six weeks, between 114 and 258 trainees and Fellows have attended the virtual presentations each week.
RANZCO has four more webinars scheduled, with Associate Professor Paul Healey, of Eye Associates, to discuss ‘Glaucoma in the time of COVID-19’ on Friday 29 May. Sydney-based Dr Ridia Lim will present on ‘Laser and glaucoma’ on 5 June, while Dr David Manning will host a webinar called ‘The glaucoma cataract: to MIGS or not to MIGS’ on 12 June.
Finally, Professor Keith Martin, from the Centre for Eye Research Australia, will discuss uveitic glaucoma on 19 June.
RANZCO created the initiative after contacting fellows asking them to consider contributing by presenting a topic. The topics are guided by the curriculum and suggestions from fellows and trainees.
According to RANZCO, the webinars are recorded and stored on the RANZCO VTP Moodle Course site, and Fellows can accrue CPD points from participating. Data from the weekly survey feedback has been “highly positive”, with RANZCO to produce a final report on the trial at the end of June.